AIMS: The aim of this study is to provide a clinical update on optic neuritis (ON), its association with multiple sclerosis (MS), and neuromyelitis optica (NMO). METHODS: This study included a PubMed review of the literature written in the English language. RESULTS: ON in adults is typically idiopathic or demyelinating, and is characterised by unilateral, subacute, painful loss of vision that is not associated with any systemic or other neurological symptoms. Demyelinating ON is associated with MS, and we review the key studies of ON including the ON treatment trial and several other MS treatment trials and NMO. CONCLUSION: Acute demyelinating ON can occur in isolation or be associated with MS. Typical ON does not require additional evaluation other than cranial magnetic resonance imaging. NMO is likely a separate disorder from MS and the ON in NMO has a different treatment and prognosis. METHODOLOGY: The authors conducted an English language search using Pubmed from the years 1964 to 2010 using the search terms 'ON', 'MS' and 'NMO'. The authors included original articles, review articles, and case reports, which revealed new aspects as far as epidemiology, histopathology, clinical manifestations, imaging, genetics, and treatment of ON. Titles were reviewed for topicality and full references were obtained. Letters to the editor, unpublished work, and abstracts were not included in this review.
AIMS: The aim of this study is to provide a clinical update on optic neuritis (ON), its association with multiple sclerosis (MS), and neuromyelitis optica (NMO). METHODS: This study included a PubMed review of the literature written in the English language. RESULTS: ON in adults is typically idiopathic or demyelinating, and is characterised by unilateral, subacute, painful loss of vision that is not associated with any systemic or other neurological symptoms. Demyelinating ON is associated with MS, and we review the key studies of ON including the ON treatment trial and several other MS treatment trials and NMO. CONCLUSION: Acute demyelinating ON can occur in isolation or be associated with MS. Typical ON does not require additional evaluation other than cranial magnetic resonance imaging. NMO is likely a separate disorder from MS and the ON in NMO has a different treatment and prognosis. METHODOLOGY: The authors conducted an English language search using Pubmed from the years 1964 to 2010 using the search terms 'ON', 'MS' and 'NMO'. The authors included original articles, review articles, and case reports, which revealed new aspects as far as epidemiology, histopathology, clinical manifestations, imaging, genetics, and treatment of ON. Titles were reviewed for topicality and full references were obtained. Letters to the editor, unpublished work, and abstracts were not included in this review.
Authors: Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; Edward G Buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A Goodwin; Barrett Katz; David I Kaufman; John L Keltner; Mark J Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall Journal: Arch Ophthalmol Date: 2003-07
Authors: Roy W Beck; Robin L Gal; M Tariq Bhatti; Michael C Brodsky; Edward G Buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A Goodwin; Barrett Katz; David I Kaufman; John L Keltner; Mark J Kupersmith; Neil R Miller; Pamela S Moke; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Jonathan D Trobe; Michael Wall; Dongyuan Xing Journal: Am J Ophthalmol Date: 2004-01 Impact factor: 5.258
Authors: T Matsushita; N Isobe; T Matsuoka; N Shi; Y Kawano; X M Wu; T Yoshiura; Y Nakao; T Ishizu; J I Kira Journal: Mult Scler Date: 2009-05-22 Impact factor: 6.312
Authors: Grazyna Adamus; Lori Brown; Shayne Andrew; Roberto Meza-Romero; Gregory G Burrows; Arthur A Vandenbark Journal: Invest Ophthalmol Vis Sci Date: 2012-01-25 Impact factor: 4.799
Authors: Reuben Grech; Kurt Spiteri Cornish; Patrick Leo Galvin; Stephan Grech; Seamus Looby; Alan O'Hare; Adrian Mizzi; John Thornton; Paul Brennan Journal: J Radiol Case Rep Date: 2014-02-01
Authors: Marcos L Aranda; Diego Guerrieri; Gonzalo Piñero; María F González Fleitas; Florencia Altschuler; Hernán H Dieguez; María I Keller Sarmiento; Mónica S Chianelli; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein Journal: Mol Neurobiol Date: 2019-05-01 Impact factor: 5.590
Authors: Patrick P K Lau; Gordon S K Yau; Jacky W Y Lee; Winnie W Y Wong; Victor T Y Tam; Eric Y T Chan; Doris M W Tse; Can Y F Yuen Journal: Int Ophthalmol Date: 2014-04-12 Impact factor: 2.031
Authors: E H Martínez-Lapiscina; E Fraga-Pumar; X Pastor; M Gómez; A Conesa; R Lozano-Rubí; B Sánchez-Dalmau; A Alonso; Pablo Villoslada Journal: J Neurol Date: 2014-02-16 Impact factor: 4.849